BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1509 related articles for article (PubMed ID: 25550339)

  • 1. Tacrolimus versus mycophenolate mofetil for induction therapy of lupus nephritis: a randomised controlled trial and long-term follow-up.
    Mok CC; Ying KY; Yim CW; Siu YP; Tong KH; To CH; Ng WL
    Ann Rheum Dis; 2016 Jan; 75(1):30-6. PubMed ID: 25550339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of a randomised controlled trial comparing tacrolimus with mycophenolate mofetil as induction therapy for active lupus nephritis.
    Mok CC; Ho LY; Ying SKY; Leung MC; To CH; Ng WL
    Ann Rheum Dis; 2020 Aug; 79(8):1070-1076. PubMed ID: 32448782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of disease activity between tacrolimus and mycophenolate mofetil in lupus nephritis: a randomized controlled trial.
    Kamanamool N; Ingsathit A; Rattanasiri S; Ngamjanyaporn P; Kasitanont N; Chawanasuntorapoj R; Pichaiwong W; Anutrakulchai S; Sangthawan P; Ophascharoensuk V; Avihingsanon Y; Sumethkul V
    Lupus; 2018 Apr; 27(4):647-656. PubMed ID: 29105558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome.
    Yap DY; Yu X; Chen XM; Lu F; Chen N; Li XW; Tang CS; Chan TM
    Nephrology (Carlton); 2012 May; 17(4):352-7. PubMed ID: 22295934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis.
    Ikeuchi H; Hiromura K; Takahashi S; Mishima K; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Kuroiwa T; Nojima Y
    Mod Rheumatol; 2014 Jul; 24(4):618-25. PubMed ID: 24252014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis.
    Chan TM; Tse KC; Tang CS; Mok MY; Li FK;
    J Am Soc Nephrol; 2005 Apr; 16(4):1076-84. PubMed ID: 15728784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive treatment for proliferative lupus nephritis.
    Tunnicliffe DJ; Palmer SC; Henderson L; Masson P; Craig JC; Tong A; Singh-Grewal D; Flanc RS; Roberts MA; Webster AC; Strippoli GF
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD002922. PubMed ID: 29957821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term data on tacrolimus treatment in lupus nephritis.
    Yap DY; Ma MK; Mok MM; Kwan LP; Chan GC; Chan TM
    Rheumatology (Oxford); 2014 Dec; 53(12):2232-7. PubMed ID: 24996908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis.
    Tamirou F; D'Cruz D; Sangle S; Remy P; Vasconcelos C; Fiehn C; Ayala Guttierez Mdel M; Gilboe IM; Tektonidou M; Blockmans D; Ravelingien I; le Guern V; Depresseux G; Guillevin L; Cervera R; Houssiau FA;
    Ann Rheum Dis; 2016 Mar; 75(3):526-31. PubMed ID: 25757867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
    Sahin GM; Sahin S; Kiziltas S; Masatlioglu S; Oguz F; Ergin H
    Ren Fail; 2008; 30(9):865-9. PubMed ID: 18925525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
    Mok CC; To CH; Yu KL; Ho LY
    Lupus; 2013 Oct; 22(11):1135-41. PubMed ID: 23995863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of lupus nephritis treated with regimens based on cyclophosphamide and mycophenolate mofetil.
    Prasad N; Kurian J; Agarwal V; Bhadauria D; Behera M; Yacha M; Kushwaha R; Agrawal V; Jain M; Gupta A
    Lupus; 2020 Jul; 29(8):845-853. PubMed ID: 32437258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes--mycophenolate mofetil treatment for lupus nephritis with addition of tacrolimus for resistant cases.
    Cortés-Hernández J; Torres-Salido MT; Medrano AS; Tarrés MV; Ordi-Ros J
    Nephrol Dial Transplant; 2010 Dec; 25(12):3939-48. PubMed ID: 20538787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis.
    Choi CB; Won S; Bae SC
    Lupus; 2018 May; 27(6):1007-1011. PubMed ID: 29448881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycophenolate mofetil or tacrolimus compared with azathioprine in long-term maintenance treatment for active lupus nephritis.
    Zhang Q; Xing P; Ren H; Chen X; Xie J; Zhang W; Shen P; Li X; Chen N
    Front Med; 2022 Oct; 16(5):799-807. PubMed ID: 35305232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis.
    Arends S; Berden JH; Grootscholten C; Derksen RH; Berger SP; de Sévaux RG; Voskuyl AE; Bijl M;
    Neth J Med; 2014 Nov; 72(9):481-90. PubMed ID: 25431394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of low-dose intravenous cyclophosphamide with oral mycophenolate mofetil in the treatment of lupus nephritis.
    Rathi M; Goyal A; Jaryal A; Sharma A; Gupta PK; Ramachandran R; Kumar V; Kohli HS; Sakhuja V; Jha V; Gupta KL
    Kidney Int; 2016 Jan; 89(1):235-42. PubMed ID: 26489028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial.
    Houssiau FA; D'Cruz D; Sangle S; Remy P; Vasconcelos C; Petrovic R; Fiehn C; de Ramon Garrido E; Gilboe IM; Tektonidou M; Blockmans D; Ravelingien I; le Guern V; Depresseux G; Guillevin L; Cervera R;
    Ann Rheum Dis; 2010 Dec; 69(12):2083-9. PubMed ID: 20833738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate versus azathioprine as maintenance therapy for lupus nephritis.
    Dooley MA; Jayne D; Ginzler EM; Isenberg D; Olsen NJ; Wofsy D; Eitner F; Appel GB; Contreras G; Lisk L; Solomons N;
    N Engl J Med; 2011 Nov; 365(20):1886-95. PubMed ID: 22087680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Lupus Nephritis Induction Treatments in a Hispanic Population: A Single-center Cohort Analysis.
    Mejía-Vilet JM; Arreola-Guerra JM; Córdova-Sánchez BM; Morales-Buenrostro LE; Uribe-Uribe NO; Correa-Rotter R
    J Rheumatol; 2015 Nov; 42(11):2082-91. PubMed ID: 26373566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.